Advanced search
Publication Cover
Cancer Investigation Volume 39, 2021 - Issue 6-7
Submit an article Journal homepage
129
Views
1
CrossRef citations to date
0
Altmetric
Article Commentary

Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma

Gary H. Lymana Fred Hutchinson Cancer Research Center, Seattle, WA, USACorrespondence[email protected]
,
Aakash Desaib Mayo Clinic School of Medicine, Rochester, MN, USA
,
Yan Leyfmanc Penn State College of Medicine, Hershey, PA, USA
&
Nicole M. Kudererd Advanced Cancer Research Group, Seattle, WA, USA
Pages 449-456 | Received 04 Jun 2021, Accepted 10 Jun 2021, Published online: 05 Jul 2021

References

  • Desai A, Gupta R, Advani S, Ouellette L, Kuderer NM, Lyman GH, et al. Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta-analysis of cohort studies. Cancer. 2021;127(9):1459–68. doi:10.1002/cncr.33386.
  • Desai A, Kuderer NM, Lyman GH. Crowdsourcing in crisis: rising to the occasion. JCO Clin Cancer Inform. 2020;4:551–4. doi:10.1200/CCI.20.00054.
  • Desai A, Warner J, Kuderer N, et al. Crowdsourcing a crisis response for COVID-19 in oncology. Nat Cancer. 2020;1–4. [epub ahead of print].
  • Grivas P, Khaki AR, Wise-Draper TM, et al. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021;32(6):787–800.
  • Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, COVID-19 and Cancer Consortium, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–18. doi:10.1016/S0140-6736(20)31187-9.
  • Kuderer NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, Warner JL. Cancer and COVID-19 - Authors' reply. Lancet. 2020;396(10257):1067–8. doi:10.1016/S0140-6736(20)32065-1.
  • Rivera DR, Peters S, Panagiotou OA, Shah DP, Kuderer NM, Hsu C-Y, et al. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study. Cancer Discov. 2020;10(10):1514–27. doi:10.1158/2159-8290.CD-20-0941.
  • Lyman GH, Kuderer NM. Randomized Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative. Cancer Invest. 2020;38(10):537–42. doi:10.1080/07357907.2020.1841922.
  • Administration UFaD: Emergency Use Authorization, 2021.
  • Administration UFaD: Convalescent Plasm EUA Letter, 2021.
  • Klassen SA, Senefeld JW, Johnson PW, et al. The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis. Mayo Clin Proc. 2021;96:1262–1275.. ;
  • Group RC. plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021;397(10289):2049–2059.
  • O'Donnell MR, Grinsztejn B, Cummings MJ, et al. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021. [epub ahead of print].
  • Thompson M, Henderson JP, Shah PK, et al. Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19. medRxiv. 2021.
  • Korn EL, Freidlin B. Methodology for comparative effectiveness research: potential and limitations. J Clin Oncol. 2012;30(34):4185–7. doi:10.1200/JCO.2012.44.8233.
  • Collins R, Bowman L, Landray M, Peto R. The magic of randomization versus the myth of real-world evidence. N Engl J Med. 2020;382(7):674–8. doi:10.1056/NEJMsb1901642.
  • Magnuson A, Bruinooge SS, Singh H, Wilner KD, Jalal S, Lichtman SM, et al. Modernizing clinical trial eligibility criteria: recommendations of the ASCO-friends of cancer research performance status work group. Clin Cancer Res. 2021;27(9):2424–9. doi:10.1158/1078-0432.CCR-20-3868.
  • Lyman GH. Comparative effectiveness research in oncology: the need for clarity, transparency and vision. Cancer Invest. 2009;27(6):593–7. doi:10.1080/07357900903109952.
  • Visvanathan K, Levit LA, Raghavan D, Hudis CA, Wong S, Dueck A, et al. Untapped potential of observational research to inform clinical decision making: American society of clinical oncology research statement. JCO. 2017;35(16):1845–54. doi:10.1200/JCO.2017.72.6414.
  • Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27:2037–49.
  • Nuttall GA, Houle TT. Liars, damn liars, and propensity scores. Anesthesiology. 2008;108(1):3–4. doi:10.1097/01.anes.0000296718.35703.20.
  • Califf RM, Hernandez AF, Landray M. Weighing the benefits and risks of proliferating observational treatment assessments: observational cacophony, randomized harmony. Jama. 2020;324(7):625–6. doi:10.1001/jama.2020.13319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.